Trial intelligence / Profile preview

Remimazolam vs propofol with alfentanil in gynecologic day surgery

ChiCTR2100053257Phase 4Recruiting

Sponsor
Weifang People's Hospital
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam + alfentanil with Propofol + alfentanil (2 arms). Primary endpoints: Anesthesia induction and maintenance success rate and Incidence of adverse events during induction and maintenance of anesthesia. Started Nov 2021; status: recruiting.

02

Drugs

remimazolampropofolalfentanil

Beyond the preview

Go deeper on ChiCTR2100053257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call